Header Logo

Connection

MIGUEL A RODRIGUEZ-BIGAS to Rectal Neoplasms

Back to Details
This is a "connection" page, showing publications MIGUEL A RODRIGUEZ-BIGAS has written about Rectal Neoplasms.
MIGUEL A RODRIGUEZ-BIGAS
Connection Strength
5.338
Rectal Neoplasms
  1. Multidisciplinary approach to recurrent/unresectable rectal cancer: how to prepare for the extent of resection. Surg Oncol Clin N Am. 2010 Oct; 19(4):847-59.
    View in: PubMed
    Score: 0.211
  2. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg. 2010 Feb; 251(2):261-4.
    View in: PubMed
    Score: 0.201
  3. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
    View in: PubMed
    Score: 0.192
  4. Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base. Ann Surg Oncol. 2008 Nov; 15(11):3036-47.
    View in: PubMed
    Score: 0.182
  5. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007 Aug; 246(2):215-21.
    View in: PubMed
    Score: 0.169
  6. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 Jun; 14(6):1870-7.
    View in: PubMed
    Score: 0.165
  7. Treatment strategies for locally recurrent rectal cancer. Eur J Surg Oncol. 2022 11; 48(11):2292-2298.
    View in: PubMed
    Score: 0.118
  8. Pathologic evaluation of total mesorectal excision: big brother is watching. J Clin Oncol. 2002 Apr 01; 20(7):1714-5.
    View in: PubMed
    Score: 0.117
  9. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer. 2022 09; 21(3):204-211.
    View in: PubMed
    Score: 0.115
  10. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer. 2022 03; 21(1):e28-e37.
    View in: PubMed
    Score: 0.113
  11. Comment on "A National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer". Ann Surg. 2021 08 01; 274(2):e197-e198.
    View in: PubMed
    Score: 0.112
  12. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg. 2001 Mar; 181(3):207-10.
    View in: PubMed
    Score: 0.108
  13. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? Dis Colon Rectum. 2019 10; 62(10):1158-1166.
    View in: PubMed
    Score: 0.098
  14. Session 4: Shaping radiotherapy for rectal cancer: should this be personalized? Colorectal Dis. 2018 05; 20 Suppl 1:92-96.
    View in: PubMed
    Score: 0.089
  15. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum. 2018 Jan; 61(1):77-83.
    View in: PubMed
    Score: 0.087
  16. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol. 2017 Aug 10; 35(23):2631-2638.
    View in: PubMed
    Score: 0.084
  17. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Am J Clin Oncol. 2017 Jun; 40(3):277-282.
    View in: PubMed
    Score: 0.084
  18. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Am J Clin Oncol. 2017 Apr; 40(2):163-166.
    View in: PubMed
    Score: 0.083
  19. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol. 2017 01; 122(1):146-151.
    View in: PubMed
    Score: 0.081
  20. Adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum. 1996 Nov; 39(11):1265-8.
    View in: PubMed
    Score: 0.080
  21. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46.
    View in: PubMed
    Score: 0.079
  22. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg. 2016 May; 103(6):753-762.
    View in: PubMed
    Score: 0.077
  23. ACR Appropriateness Criteria? Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol. 2015 Oct; 38(5):520-5.
    View in: PubMed
    Score: 0.075
  24. Reply to N.H. Turner et al and L. Dziki et al. J Clin Oncol. 2015 Apr 20; 33(12):1412-3.
    View in: PubMed
    Score: 0.072
  25. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surg. 2015 Mar 01; 150(3):245-51.
    View in: PubMed
    Score: 0.072
  26. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22.
    View in: PubMed
    Score: 0.071
  27. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.069
  28. Pelvic neuroanatomy and technique of abdominoperineal resection of the rectum for cancer. Arch Surg. 2004 Feb; 139(2):225; author reply 225.
    View in: PubMed
    Score: 0.066
  29. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer. 2014 Apr 15; 120(8):1162-70.
    View in: PubMed
    Score: 0.066
  30. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):301-5.
    View in: PubMed
    Score: 0.066
  31. Impact of ileostomy-related complications on the multidisciplinary treatment of rectal cancer. Ann Surg Oncol. 2014 Feb; 21(2):507-12.
    View in: PubMed
    Score: 0.065
  32. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer. 2013 Dec 15; 119(24):4231-41.
    View in: PubMed
    Score: 0.065
  33. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013 Aug; 148(8):769-77.
    View in: PubMed
    Score: 0.064
  34. An individualized conditional survival calculator for patients with rectal cancer. Dis Colon Rectum. 2013 May; 56(5):551-9.
    View in: PubMed
    Score: 0.063
  35. Metformin use and improved response to therapy in rectal cancer. Cancer Med. 2013 Feb; 2(1):99-107.
    View in: PubMed
    Score: 0.062
  36. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013 Feb; 56(2):135-41.
    View in: PubMed
    Score: 0.062
  37. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012 Dec; 55(12):1213-9.
    View in: PubMed
    Score: 0.061
  38. ACR appropriateness criteria???resectable rectal cancer. Radiat Oncol. 2012 Sep 24; 7:161.
    View in: PubMed
    Score: 0.060
  39. Surgery for recurrent rectal adenocarcinoma in the presence of hydronephrosis. Am J Surg. 1992 Jul; 164(1):18-21.
    View in: PubMed
    Score: 0.059
  40. Technique for packing the perineal wound after a wide perineal dissection for adenocarcinoma of the rectum. Am Surg. 1992 May; 58(5):277-9.
    View in: PubMed
    Score: 0.059
  41. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012 May 20; 30(15):1770-6.
    View in: PubMed
    Score: 0.059
  42. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol. 2012 Sep; 19(9):2814-21.
    View in: PubMed
    Score: 0.058
  43. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Dis Colon Rectum. 2012 Apr; 55(4):371-7.
    View in: PubMed
    Score: 0.058
  44. Reverse-hybrid robotic mesorectal excision for rectal cancer. Dis Colon Rectum. 2012 Feb; 55(2):228-33.
    View in: PubMed
    Score: 0.058
  45. Intrathecal phenol rhizotomy for management of pain in recurrent unresectable carcinoma of the rectum. Surg Gynecol Obstet. 1991 Jul; 173(1):41-4.
    View in: PubMed
    Score: 0.055
  46. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer. 2011 Aug 15; 117(16):3713-22.
    View in: PubMed
    Score: 0.054
  47. Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2011 Apr; 18(4):989-96.
    View in: PubMed
    Score: 0.053
  48. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010 Nov; 17(11):2863-9.
    View in: PubMed
    Score: 0.052
  49. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer. 2009 Dec 01; 115(23):5432-40.
    View in: PubMed
    Score: 0.050
  50. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010 Feb; 17(2):441-7.
    View in: PubMed
    Score: 0.049
  51. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):60-5.
    View in: PubMed
    Score: 0.049
  52. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical course. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):818-23.
    View in: PubMed
    Score: 0.047
  53. Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg. 2008 Apr; 206(4):694-703.
    View in: PubMed
    Score: 0.044
  54. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1175-80.
    View in: PubMed
    Score: 0.044
  55. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 2008 Jan 20; 26(3):368-73.
    View in: PubMed
    Score: 0.044
  56. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007 May 01; 109(9):1750-5.
    View in: PubMed
    Score: 0.042
  57. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71.
    View in: PubMed
    Score: 0.040
  58. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1378-83.
    View in: PubMed
    Score: 0.040
  59. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
    View in: PubMed
    Score: 0.039
  60. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.
    View in: PubMed
    Score: 0.038
  61. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4.
    View in: PubMed
    Score: 0.035
  62. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys. 2004 Nov 15; 60(4):1098-105.
    View in: PubMed
    Score: 0.035
  63. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
    View in: PubMed
    Score: 0.033
  64. Perineal dissection of synchronous abdominoperineal resection of the rectum: an anatomical description. Arch Surg. 2003 May; 138(5):553-9.
    View in: PubMed
    Score: 0.032
  65. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003 Jan 15; 97(2):517-24.
    View in: PubMed
    Score: 0.031
  66. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum? J Surg Oncol. 2002 Sep; 81(1):3-7.
    View in: PubMed
    Score: 0.030
  67. Absorbable mesh sling prevents radiation-induced bowel injury during "sandwich" chemoradiation for rectal cancer. Arch Surg. 2000 Oct; 135(10):1212-7.
    View in: PubMed
    Score: 0.026
  68. Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg. 2000 Apr; 179(4):271-4.
    View in: PubMed
    Score: 0.025
  69. Utility of routine postoperative laboratory studies in patients undergoing potentially curative resection for adenocarcinoma of the colon and rectum. Cancer Invest. 1999; 17(2):102-9.
    View in: PubMed
    Score: 0.023
  70. Colovaginal anastomosis: a unique complication of end-to-end anastomosis stapler use in low anterior resection. Am Surg. 1998 Nov; 64(11):1023-6.
    View in: PubMed
    Score: 0.023
  71. Absence of frequent involvement of modifier of Min(APC) in sporadic colorectal cancer. Ann Surg Oncol. 1998 Mar; 5(2):181-5.
    View in: PubMed
    Score: 0.022
  72. Complications of absorbable pelvic mesh slings following surgery for rectal carcinoma. Dis Colon Rectum. 1997 Nov; 40(11):1336-41.
    View in: PubMed
    Score: 0.022
  73. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997 Feb; 225(2):202-7.
    View in: PubMed
    Score: 0.020
  74. Primary signet-ring cell carcinoma of the colon and rectum. Ann Surg Oncol. 1996 Jul; 3(4):344-8.
    View in: PubMed
    Score: 0.020
  75. Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens. Surg Oncol. 1996 Jun; 5(3):123-6.
    View in: PubMed
    Score: 0.020
  76. Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma. Cancer Invest. 1996; 14(1):1-5.
    View in: PubMed
    Score: 0.019
  77. Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. Cancer Invest. 1996; 14(5):491-7.
    View in: PubMed
    Score: 0.019
  78. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Radiology. 1995 Dec; 197(3):688-92.
    View in: PubMed
    Score: 0.019
  79. Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer. Ann Surg Oncol. 1995 May; 2(3):228-32.
    View in: PubMed
    Score: 0.018
  80. Inguinal lymph node metastases from adenocarcinoma of the rectum. Am J Surg. 1994 Sep; 168(3):285-7.
    View in: PubMed
    Score: 0.017
  81. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma. Cancer. 1993 Sep 01; 72(5):1543-6.
    View in: PubMed
    Score: 0.016
  82. Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma. Am Surg. 1993 Jul; 59(7):400-4.
    View in: PubMed
    Score: 0.016
  83. High prevalence of Inoue-Melnick virus antibodies in patients with colorectal carcinoma. Cancer Lett. 1992 Aug 31; 65(3):233-7.
    View in: PubMed
    Score: 0.015
  84. Accuracy of biopsy and cytology for the preoperative diagnosis of colorectal adenocarcinoma. J Surg Oncol. 1999 May; 71(1):46-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.